Endostatin/Angiostatin gene therapy (Genetix)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEndostatin/Angiostatin gene therapy (Genetix)
Drug Alias Namesolid tumor gene therapy (Genetix)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenetix Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenetix Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A